Infertility
📧 Sign up to get email alerts when something new happens for Infertility.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-03-12Clinical Trial Update: Pilot Study on Molecular Quantitation and Sequencing of Endometrial Cytokines Gene Expression and Their Effect on the Outcome of In-vitro Fertilization (IVF) Cycle
A pilot study from Cairo University quantifies and sequences endometrial cytokine gene expression to evaluate its effect on IVF cycle outcom…
-
CLINICAL_TRIALS research · 2013-03-12Clinical Trial Update: A New Tool for Automatic Ovarian Follicle Count and it Abilities to Evaluate Ovarian Reserve
Clinical trial update on a new automated tool for counting ovarian follicles and evaluating ovarian reserve in infertility. The current stat…
-
CLINICAL_TRIALS research · 2013-03-06Clinical Trial Update: Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women [NA]
ClinicalTrials.gov entry evaluating two regimens for clomiphene-resistant infertility in PCOS: clomiphene citrate with uFSH versus an aromat…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Use of r-hLH (Luveris) in Donors Previously Treated With r-hFSH (Gonal F) [NA]
Completed clinical trial evaluating outcomes during r-hFSH stimulation and during combined r-hFSH and r-hLH stimulation in egg donors previo…
-
CLINICAL_TRIALS research · 2013-02-27Clinical Trial Update: Endometrial Biopsy Prior to IVF in Those Patients With Prior Implantation Failure [NA]
Clinical trial update investigating whether performing an endometrial biopsy before IVF benefits patients with prior implantation failure.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-02-20FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)
The FDA approved a supplemental application for GONAL-F (follitropin alfa) from EMD Serono, Inc.
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age [Phase 2]
Phase II study evaluating Luveris (lutropin alfa) in mid-follicular phase for controlled ovarian stimulation in advanced reproductive age; t…
-
FDA approval · 2013-02-19FDA Approved: GONAL-F RFF REDI-JECT — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for GONAL-F RFF REDI-JECT (follitropin) by EMD Serono, Inc., adding the REDI-JECT delivery system to…
-
FDA approval · 2013-02-19FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for GONAL-F (follitropin alfa) submitted by EMD Serono, Inc., resulting in an approved update to the…
-
FDA approval · 2013-02-19FDA Approved: CLOMID — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for CLOMID (clomiphene citrate) by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2013-02-15FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)
The FDA approved a supplemental application for GONAL-F (FOLLITROPIN ALFA) submitted by EMD Serono, Inc.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in IVF Cycles [Phase 4]
Phase 4 clinical trial evaluating whether administering clomiphene citrate during the early luteal phase alters the endocrine profile in IVF…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation [Phase 4]
Completed Phase 4 clinical trial comparing GnRH antagonist with GnRH agonist for endometrium preparation in oocyte recipient cycles.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Beneficial Effect of Adding Pentoxifylline to Processed Semen Samples on ICSI Outcome in Infertile Males [NA]
A clinical trial update suggests that adding pentoxifylline to processed semen may improve ICSI outcomes in infertile males.
-
FDA approval · 2013-02-14FDA Approved: GONAL-F RFF REDI-JECT — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for GONAL-F RFF REDI-JECT, a follitropin product for fertility treatment, submitted by EMD Serono, I…
-
FDA approval · 2013-02-14FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for GONAL-F (follicle-stimulating alfa) submitted by EMD Serono, Inc.
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: The Effect of Stress on DNA Integrity and the Effect of Cognitive Behavioral Therapy on Stress and Infertility in Women [NA]
This clinical trial investigated whether stress affects DNA integrity and whether cognitive-behavioral therapy can reduce stress and inferti…
-
CLINICAL_TRIALS research · 2013-02-11Clinical Trial Update: Unexplained Infertility Among Asthmatic and Atopic Patients
This clinical trial update covers a study of unexplained infertility in atopic patients. The status of the trial is unknown.
-
FDA approval · 2013-02-08FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)
The FDA approved a supplemental application for GONAL-F (folitropin alfa) submitted by EMD Serono, Inc.
-
FDA approval · 2013-02-06FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)
FDA has approved a supplemental application for GONAL-F (foltropin alfa) submitted by EMD Serono, Inc.
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing Study [Phase 4]
This Phase 4 trial compared anti-Müllerian hormone–guided dosing to antral follicle count–guided dosing of recombinant FSH in infertility pa…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Evaluation of IMSI to Treat Male Infertility [NA]
This clinical trial update reports on the evaluation of IMSI (intracytoplasmic morphologically selected sperm injection) to treat male infer…
-
FDA approval · 2013-01-31FDA Approved: OVIDREL — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for OVIDREL (chorionic gonadotropin alfa) submitted by EMD Serono, Inc.
-
FDA approval · 2013-01-31FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)
The FDA approved a supplemental application for GONAL-F (follitropin alfa) submitted by EMD Serono, Inc.
-
FDA approval · 2013-01-31FDA Approved: GONAL-F RFF REDI-JECT — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for GONAL-F RFF REDI-JECT (follitropin) submitted by EMD Serono, Inc. The action approves changes to…